OREANDA-NEWS. July 03, 2012. An annual meeting of JSC  PROTEK, one of Russia’s largest pharmaceutical holdings, was held. At the annual meeting shareholders made a decision on dividend payment for the previous period (2010, as well as based on the results of 2011 and Q1-2012). The total amount of dividends accrued is RUR943,585,714.

In addition, a decision on election of the Board of Directors consisting of 7 members was made. The new Board of Directors includes its previous members: Chairman of the Board of Directors Vadim Sergeevich Yakunin, President of JSC  Protek Vadim Gennadievich Muzyaev, Economic Director of JSC  Protek Yulija Sergeevna Yakunina, Deputy IT Director General of LLC  Rigla Vadim Nikolaevich Gorbunov, Principal Counselor to the Head of the Main Administration for Service to the Diplomatic Corps under the Ministry of Foreign Affairs of the Russian Federation Aleksandr Nikolaevich Suhoruchenko (independent member of the Board of Directors), Director General of StratinvestRu Leonid Mikhailovich Sevastianov (independent member of the Board of Directors), Head of Gradient Group Leonid Romanovich Novoselskiy (independent member of the Board of Directors).

Shareholders also approved recommendations of the company’s Board of Directors on the payment of remuneration to members of the Board of Directors in the amount of RUR1.5 mln per year each after taxes.

In addition, shareholders approved the annual report of JSC  Protek for 2011, elected the Audit Committee and approved LLC  Baker Tilly Russaudit as an auditor according to Russian Accounting Standards and ZAO PricewaterhouseCoopers Audit according to International Financial Reporting Standards.